MARSHALL WACE, LLP - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 144 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$101,000
-99.0%
314,316
-93.0%
0.00%
-100.0%
Q4 2021$10,114,000
-49.6%
4,475,138
-35.8%
0.02%
-77.1%
Q3 2021$20,070,000
+28.9%
6,968,811
+69.6%
0.08%
+18.6%
Q2 2021$15,575,000
+15956.7%
4,109,589
+10552.7%
0.07%
+6900.0%
Q3 2020$97,000
-98.0%
38,578
-89.3%
0.00%
-97.1%
Q2 2020$4,902,000
+703.6%
360,967
+384.4%
0.03%
+1033.3%
Q1 2019$610,000
-79.3%
74,526
-86.0%
0.00%
-90.0%
Q4 2018$2,953,000
-69.0%
533,941
-50.5%
0.03%
-25.0%
Q3 2018$9,520,000
+76.9%
1,078,128
+99.9%
0.04%
-50.6%
Q2 2018$5,382,000
+140.6%
539,259
+129.7%
0.08%
-12.9%
Q1 2018$2,237,000
-26.3%
234,769
+15.0%
0.09%
-27.3%
Q4 2017$3,036,000
+68.9%
204,196
+127.3%
0.13%
+52.4%
Q3 2017$1,797,000
+31.9%
89,847
-7.7%
0.08%
+40.0%
Q2 2017$1,362,000
+187.3%
97,294
+84.6%
0.06%
+160.9%
Q1 2017$474,000
-93.4%
52,717
-92.3%
0.02%
-51.1%
Q4 2016$7,167,000
+27.3%
688,470
+10.7%
0.05%
+17.5%
Q3 2016$5,628,000
+63.0%
621,850
+34.7%
0.04%
+37.9%
Q2 2016$3,452,000
-15.7%
461,517
+1.5%
0.03%
-25.6%
Q1 2016$4,096,000
-14.7%
454,606
+22.3%
0.04%
-13.3%
Q4 2015$4,802,000
+16.1%
371,675
-13.2%
0.04%
-11.8%
Q3 2015$4,135,000
+0.5%
428,032
+7.0%
0.05%
-5.6%
Q2 2015$4,116,000400,0000.05%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$3,340,0005.66%
Orchard Capital Management, LLC 1,762,731$1,265,0000.36%
Ikarian Capital, LLC 1,200,000$860,0000.11%
Ikarian Capital, LLC 800,000$575,0000.08%
XTX Topco Ltd 102,392$74,0000.03%
Nantahala Capital Management 965,800$693,0000.03%
Worth Venture Partners, LLC 63,500$46,0000.02%
Ardent Capital Management, Inc. 43,429$31,0000.02%
Virtus ETF Advisers LLC 65,149$47,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 513,292$368,0000.02%
View complete list of AKEBIA THERAPEUTICS INC shareholders